跳至主要内容
临床试验/JPRN-UMIN000012473
JPRN-UMIN000012473已完成未知

Study for variations of safety and efficacy profile caused by division of weekly dose of methotrexate (preliminary study) - SAME study

Yokohama Minami Kyousai Hospital Santen Pharmaceutical CO.,Ltd.0 个研究点目标入组 40 人开始时间: 2013年12月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

There were no significant differences in the average of age , disease duration (5.8yr), and baseline DAS28(CPR)(2.84) between two groups. There were also no differences in the improvement of DAS28(CPR)(-0.95 vs -0.75) between two groups and weekly MTX dose(11.5mg vs 11.4mg) . Three adverse events were observed only in 3-dose regimen group . The remarkable difference was observed in MTX-PGs(18.8%), 3-dose regimen group showed significantly higher concentration of MTX-PG1+2 than single-dose group. On the other hand, 3-doses regimen group showed slight lower MTX-PG4+5 than single-dose regimen group, and there was no difference in MTX-PG3. The efficacy did not show significant difference between two groups. Liver function may be affected by concentration of MTX-PG1+2, which elevated in divided dosage regimen group. Further investigation is required in a larger population.

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (Complication) Patients who had any of the following diagnoses or medical history 1)Autoimmune disease, except for RA and Sjogren's syndrome, and malignancy. 2)Drug allergy 3)Severe heart, lung, liver, kidney and heamatological disorders (Treatment) 4)Patient who recived intramuscular, intoravenous or epidural injection of corticosteroids within 4 weeks prior to the entry or during study 5)Patient who recived intraarticular corticosteroid at dose of over 20mg/month of prednisolone, and patients who recieved intraarticular corticosteroid at any dose within 4weeks prior to study entry or the day for observation of first end point 6)Patient who recived systemic corticosteroid with a dose of>10mg of predonisolone within 4 weeks prior to the study or during the study and Patients whose corticosteroid dose were changed within 4 weeks prior to the day for observation of first end point 7)Patient who received NSAIDs with an overdosage within 4 weeks prior to the study entry or during the study (Surgery) 8)Patient who had surgery judged to have an influence on this study by doctor 9)Patient who had the following treatment or procedure:plasma exchange, leukocyte depleted therapy or arthrocentesis against affected joint. except for the arthrocenesis following intraarticular injection of corticosteroid, within 4 weeks prior to the study entry or during the study (Others) 10)Patient who is in pregnancy, lactating, or with a possibility of the pregnancy and woman who hopes for pregnancy during study or within 1 month after the end of this study, and man who wishes his partner be pregnant during the study or within 3 months after the end of this study 11)Patient who can not go to a hospital for check-up on an appointed day 12)When principal investigator or sub investigators of this study judge the patients disqualified as a subject of this study

研究者

发起方
Yokohama Minami Kyousai Hospital Santen Pharmaceutical CO.,Ltd.

相似试验

已完成
4 期
A prospective randomized clinical trial, the effect of long acting CCBs in post-acute myocardial infarction patientsST-segment elevation myocardial infarction(STEMI) or non-ST elevation myocardial infarction(NSTEMI)
JPRN-UMIN000010091Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University97
已完成
不适用
'A clinical study of the difference in the effect of pocket-irrigation in the treatment of peri-implantitis compared to a conventional therapy, the airflow: a randomized controlled trial'infection of the gums surrounding an implant10004018
NL-OMON51972niversitair Medisch Centrum Groningen60
已完成
4 期
Comparison the Clinical Effectiveness of Radial Shockwave Therapy and Ultrasound Therapy for Treatment of Chronic De Quervain DiseaseChronic de quervain diseaseChronic De Quervain disease,Radial extracorporeal shockwave therapy,Ultrasound therapy
TCTR20240513001Faculty of Medicine Ramathibodi Hospital, Mahidol University28
招募中
4 期
A study comparing vilazodone with escitalopram in terms of efficacy , safety and onset of action in patients with depression.
CTRI/2019/01/017302Dr Ankushe rohini
已完成
不适用
Comparison of Visual Outcomes and Complications of Phacoemulsification with Intraocular Lens Implantation between Nanophthalmos and Normal Eyes.anophthalmic patient and normal control eyes with cataract who underwent phacoemulsification with IOLs implantation in ophthalmology training center between 2014 and 2020.Nanophthalmos, Cataract Surgery, small eye
TCTR20230208008/A2